Johnson & Johnson announces Chris DelOrefice as vice president of investor relations

Johnson & Johnson has appointed Chris DelOrefice as Vice President of Investor Relations for Johnson & Johnson, effective August 13, 2018. DelOrefice will report to Joseph Wolk, executive vice president and chief financial officer of the company. DelOrefice has been with Johnson & Johnson for 19 years and has most recently served as the CFO of the North America Hospital Medical Devices (MD) Business. In this role, he provided strategic financial leadership and counsel, which were integral in evolving the MD portfolio and commercial strategy to support our long-term growth. Previously, DelOrefice held various leadership positions across all three segments of Johnson & Johnson and many functions of the company, and was instrumental in leading key mergers and acquisitions, negotiating critical licensing and managed care agreements and implementing major business restructurings.